Funding a Clinical Trial: The Perspective of a Medicines Funder

Author： Alsop Peter   Metcalfe Scott   Evans Jackie  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.10, 2008-01, pp. : 811-814

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Time for a Single System for Funding Medicines

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 41, Iss. 1, 2011-03 ,pp. : 12-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selective Reporting, Publication Bias and Clinical Trial Registry: An Industry Perspective

By Berlin Jesse A.  

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 5-6, 2005-01 ,pp. : 277-284

Adis International

Access to resources Recommend Favorite

Clinical Development and Trial Design of Biosimilar Products: A Japanese Perspective

By    

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 6, 2014-11 ,pp. : 1165-1172

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmacovigilance of Herbal Medicines: A UK Perspective

By Barnes J.  

Drug Safety, Vol. 26, Iss. 12, 2003-01 ,pp. : 829-851

Adis International

Access to resources Recommend Favorite

The New European Regulation on Pediatric Medicines: Regulatory Perspective

By Hawcutt Daniel B.   Smyth Rosalind L.  

Pediatric Drugs, Vol. 10, Iss. 3, 2008-01 ,pp. : 143-146

Adis International

Access to resources Recommend Favorite